This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cochrane, M. Articles by Timms, P. Search for Related Content PubMed PubMed Citation Articles by Cochrane, M. Articles by Timms, P.

Distribution of Chlamydia pneumoniae DNA in Atherosclerotic Carotid Arteries: Significance for Sampling Procedures

Center for Molecular Biotechnology, Queensland University of Technology,¹ Department of Surgery, Royal Brisbane Hospital, University of Queensland,³ Princess Alexandra Hospital, Brisbane, Australia,⁴ Institute of Veterinary Pathology, University of Zurich, Zurich, Switzerland²

Received 1 April 2002/ Returned for modification 29 September 2002/ Accepted 14 December 2002

Despite extensive efforts to confirm a direct association between Chlamydia pneumoniae and atherosclerosis, different laboratories continue to report a large variability in detection rates. In this study, we analyzed multiple sections from atherosclerotic carotid arteries from 10 endartectomy patients to determine the location of C. pneumoniae DNA and the number of sections of the plaque required for analysis to obtain a 95% confidence of detecting the bacterium. A sensitive nested PCR assay detected C. pneumoniae DNA in all patients at one or more locations within the plaque. On average, 42% (ranging from 5 to 91%) of the sections from any single patient had C. pneumoniae DNA present. A patchy distribution of C. pneumoniae in the atherosclerotic lesions was observed, with no area of the carotid having significantly more C. pneumoniae DNA present. If a single random 30-µm-thick section was tested, there was only a 35.6 to 41.6% (95% confidence interval) chance of detecting C. pneumoniae DNA in a patient with carotid artery disease. A minimum of 15 sections would therefore be required to obtain a 95% chance of detecting all true positives. The low concentration and patchy distribution of C. pneumoniae DNA in atherosclerotic plaque appear to be among the reasons for inconsistency between laboratories in the results reported.

This article has been cited by other articles:

• Ieven, M. M., Hoymans, V. Y. (2005). Involvement of Chlamydia pneumoniae in Atherosclerosis: More Evidence for Lack of Evidence. J. Clin. Microbiol. 43: 19-24 [Full Text]  
• Apfalter, P., Barousch, W., Nehr, M., Willinger, B., Rotter, M., Hirschl, A. M. (2004). No Evidence of Involvement of Chlamydia pneumoniae in Severe Cerebrovascular Atherosclerosis by Means of Quantitative Real-Time Polymerase Chain Reaction. Stroke 35: 2024-2028 [Abstract] [Full Text]